Reach Us +44-1477412632
IgA Nephropathy In Patients Receiving A Renal Transplant | 50512
ISSN: 2161-0959

Journal of Nephrology & Therapeutics
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

IgA nephropathy in patients receiving a renal transplant

9th International Conference on Dialysis and Renal Care

Lemes-Canuto APPS, de Sandes-Freitas TV, Medina-Pestana JO and Mastroianni-Kirsztajn G

Hospital de Base de Brasilia, Brazil

ScientificTracks Abstracts: J Nephrol Ther

DOI: 10.4172/2161-0959.C1.027

Background: IgA nephropathy (IgAN) is the third most frequent cause of renal graft loss among patients with primary glomerulonephritis. Objectives: To assess clinical and laboratorial profile of patients with pre and/or post transplant IgAN, in addition to patient and graft survival in both groups. Design: Data from 146 patients who had received a renal transplant were retrospectively collected and were divided in two groups: group 1-patients with biopsy-documented IgAN as the underlying native kidney disease (n 1⁄4 128); group 2-patients who developed post-transplant IgAN independent of the underlying disease (n 1⁄4 18). Participants: Patients submitted to renal transplantation (1998–2010) with pre and/or post transplant IgAN. Measurements: Clinical and laboratorial evaluation of renal function of 146 post transplant IgAN patients. Results: Recipients and deceased donors exhibited a higher degree of HLA compatibility (1.0 vs. 2.5 mismatches for groups 1 and 2, respectively). The main post-transplant IgAN presentation was haematuria associated with non-nephrotic proteinuria (44.4%). A histological pattern of focal segmental glomerulosclerosis was observed in 59.2% of biopsy samples. The 10-year patient survival was 93.5% in group 1 and 100% in group 2, and the graft survival rates were 58.5 and 87.2%, respectively. Conclusion: The rate of post-transplant IgA diagnosis in our case series was 11%, and IgAN was diagnosed late in the course of transplantation. In most cases, IgAN manifested as haematuria and non-nephrotic proteinuria, without renal graft dysfunction, and this picture might explain late indication of graft biopsies. The 10-year patient survival rates were excellent.

Lemes-Canuto APPS has completed her graduation in Medicine at the University of Ribeirao Preto/UNAERP (2003). She has a specialist title in Nephrology by the Brazilian Society of Nephrology, and Master’s degree in Health Sciences by the Federal University of Sao Paulo/UNIFESP, in the area of Nephrology/Glomerulopathy. At present, she works as a Nephrologist in an outpatient clinic in the area of Glomerulopathies in Federal District and in the Clinic of Uraemia in the Hospital of the University of Brasilia/ UNB-HUB.

Email: [email protected]